In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.

被引:8
|
作者
Croco, MAT [1 ]
Biedenbach, DJ [1 ]
Pfaller, MA [1 ]
Doern, GV [1 ]
Jones, RN [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Pathol, Div Med Microbiol, Iowa City, IA 52242 USA
关键词
D O I
10.1093/jac/42.5.672
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:672 / 673
页数:2
相关论文
共 50 条
  • [1] In-vitro activity of gatifloxacin, a novel fluoroquinolone, compared with that of ciprofloxacin against Legionella spp.
    Pendland, SL
    Losnedahl, KJ
    Schriever, CA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) : 295 - 297
  • [2] The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp.
    Ridgway, GL
    Salman, H
    Robbins, MJ
    Dencer, C
    Felmingham, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 : 31 - 34
  • [3] Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model
    Hershberger, E
    Rybak, MJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 598 - 601
  • [4] Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
    Gómez-Lus, R
    Adrián, F
    del Campo, R
    Gómez-Lus, P
    Sánchez, S
    García, C
    Rubio, MC
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (01) : 49 - 54
  • [5] In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria
    Wexler, HM
    Molitoris, E
    Molitoris, D
    Finegold, SM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (09) : 2232 - 2235
  • [6] In-vitro antifungal susceptibilities of Basidiobolus and Conidiobolus spp. strains
    Guarro, J
    Aguilar, C
    Pujol, I
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) : 557 - 560
  • [7] In Vitro Activities of Hexaazatrinaphthylenes against Leishmania spp.
    Lopez-Arencibia, Atteneri
    Garcia-Velazquez, Daniel
    Martin-Navarro, Carmen M.
    Sifaoui, Ines
    Reyes-Batlle, Maria
    Lorenzo-Morales, Jacob
    Gutierrez-Ravelo, Angel
    Pinero, Jose E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (05) : 2867 - 2874
  • [8] IN-VITRO AND IN-VIVO ACTIVITIES OF SPARFLOXACIN AGAINST MYCOPLASMA-PNEUMONIAE
    KAKU, M
    ISHIDA, K
    IRIFUNE, K
    MIZUKANE, R
    TAKEMURA, H
    YOSHIDA, R
    TANAKA, H
    USUI, T
    TOMONO, K
    SUYAMA, N
    KOGA, H
    KOHNO, S
    HARA, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) : 738 - 741
  • [9] Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci
    von Eiff, C
    Peters, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) : 569 - 573
  • [10] Comparative in-vitro activity of levofloxacin against Chlamydia spp.
    Donati, M
    Rumpianesi, F
    Marchetti, F
    Sambri, V
    Cevenini, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) : 670 - 671